Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by Universitaire Ziekenhuizen Leuven.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Chantal Van Ongeval, MD, Phd, Universitaire Ziekenhuizen Leuven
First received: May 14, 2012
Last updated: September 12, 2012
Last verified: September 2012
Evaluation of the response to chemotherapy in breast cancer patients by the use of Diffusion-weighted magnetic resonance imaging of the breast before the start of chemotherapy, after one and 3 cycles of therapy and at the end of the therapy.
||Observational Model: Cohort
Time Perspective: Prospective
||Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation
Primary Outcome Measures:
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||March 2013 (Final data collection date for primary outcome measure)
women with breast cancer and chemotherapy
women recently diagnosed with breast cancer and selected to start with neo-adjuvant chemotherapy (6 cycles) before surgery/therapy
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
women diagnosed with breast cancer and treated with neo-adjuvant chemotherapy
- core biopsy with diagnosis of breast cancer
- start of neo-adjuvant chemotherapy
- magnetic resonance imaging incompatibility
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01684735
|University Hospitals Leuven
|Leuven, Belgium, 300 |
|Contact: Hilde Vandenhoutte, Phd (0)16343636 email@example.com |
|Principal Investigator: Chantal Van Ongeval, MD,Phd |
Universitaire Ziekenhuizen Leuven
||Chantal Van Ongeval, MD, Phd
||Universitaire Ziekenhuizen Leuven
No publications provided
||Chantal Van Ongeval, MD, Phd, MD,Phd, Universitaire Ziekenhuizen Leuven
History of Changes
|Other Study ID Numbers:
|Study First Received:
||May 14, 2012
||September 12, 2012
||Belgium: Institutional Review Board
Keywords provided by Universitaire Ziekenhuizen Leuven:
ClinicalTrials.gov processed this record on May 21, 2015
diffusion-weighted magnetic resonance imaging